Purchase Order 19PCRD26K1497
Award Date 12/8/25
Potential Completion Date 1/2/26
Potential Value $25K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Durham, NC 27701, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Bureau of Administration awarded a $24,928.33 firm fixed-price purchase order to GlaxoSmithKline, LLC for medical supplies on December 8, 2025, with an ultimate completion date of January 2, 2026. The contract, which carries no set-aside designation, will be performed in Durham, North Carolina, where GlaxoSmithKline maintains its headquarters. As a foreign-owned pharmaceutical company, GlaxoSmithKline serves as a prime contractor and supplier of vaccines, antiviral medications, and...
- This is a $105,351.10 delivery order contract awarded by the Department of Health and Human Services (HHS) to Glaxosmithkline, LLC, a foreign-owned for-profit pharmaceutical company, for the supply of vaccines. The contract is not set-aside and was awarded under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract vehicle. The vaccines will be delivered from Glaxosmithkline's facilities in Research Triangle Park, North Carolina. Glaxosmithkline has a range of federal...
- This contract was awarded by the Department of Health and Human Services Office of the Assistant Secretary for Administration to the prime contractor Glaxosmithkline, LLC, a foreign-owned for-profit pharmaceutical company, to provide vaccines for the government's stock. The $172,923.02 firm fixed price delivery order was issued under Glaxosmithkline's Federal Supply Schedule 61-IB contract for pharmaceuticals and drugs. The award does not have a set-aside designation. Glaxosmithkline is a...
- The U.S. government agency, the Medical Supply Chain, has awarded a $1,400.00 firm fixed price delivery order contract to Glaxosmithkline, LLC, a pharmaceutical company, for the provision of influenza virus vaccines. This contract has no set-aside designation and the performance will take place at Glaxosmithkline's facilities in Durham, North Carolina. Glaxosmithkline has also received several other federal contracts and grants to supply a range of pharmaceutical products and services, including...
- The U.S. government's Bureau of Administration, a civilian agency, awarded a firm fixed-price delivery order contract to GlaxoSmithKline, LLC for the provision of 2025-2026 influenza vaccines. The contract has a ceiling value of $667,575.00 and an ultimate completion date of October 9, 2025. This award is not set aside for any specific business type. GlaxoSmithKline, a foreign-owned, for-profit pharmaceutical company, has been a critical supplier of vaccines, antivirals, and medical...
- This is a delivery order issued under the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) Pandemic Influenza Preparedness and Response 2016-2021 contract vehicle. The $2,064,652.60 firm fixed price contract was awarded to Glaxosmithkline, LLC to provide a range of pharmaceutical goods and services, including influenza vaccines, antiviral medications, vaccine adjuvants, and COVID-19 treatments. Glaxosmithkline, a foreign-owned...
- This is a federal delivery order contract awarded by the Office of the Assistant Secretary for Administration, a civilian agency, to GlaxoSmithKline, LLC, a pharmaceutical company. The contract is for the procurement of vaccines for the government's stockpile, with a ceiling value of $88,962.20. The contract was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and is a firm fixed-price arrangement. GlaxoSmithKline has provided a range of pharmaceutical products...
- This federal contract award to Glaxosmithkline, LLC was issued by the Department of Health and Human Services for the delivery of vaccines. The $78,273.48 firm fixed price Delivery Order was placed under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract supports government vaccine stockpiling efforts, with performance occurring at Glaxosmithkline's facilities in North Carolina. The contract has no set-aside designation. Glaxosmithkline is a major pharmaceutical...
- This is a federal contract awarded by the Department of Health and Human Services Office of the Assistant Secretary for Administration to Glaxosmithkline, LLC, a pharmaceutical company, for the delivery of vaccines, antiviral medications, and other pharmaceutical products. The contract is a delivery order issued under Glaxosmithkline's existing General Services Administration Federal Supply Schedule 61 for Pharmaceuticals and Drugs, with a firm fixed price of $138,736.39. The contract has a...
- This federal contract award to Glaxosmithkline, LLC ("Glaxosmithkline") is for the delivery of vaccines for the U.S. government. The $194,863.47 firm fixed price contract was awarded by the Office of the Assistant Secretary for Administration, a civilian federal agency, and is associated with the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) indefinite delivery vehicle. The contract has no set-aside designation and the place of performance is Glaxosmithkline's...